SIEWERT TYPE 1 GEJ CANCER

Clinical trials for SIEWERT TYPE 1 GEJ CANCER explained in plain language.

Never miss a new study

Get alerted when new SIEWERT TYPE 1 GEJ CANCER trials appear

Sign up with your email to follow new studies for SIEWERT TYPE 1 GEJ CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Two-Pronged attack on tough cancers shows promise

Disease control Ongoing

This study is testing whether adding an experimental drug called futibatinib to standard immunotherapy and chemotherapy can better control advanced esophageal or pancreatic cancer. It is for adults who have not yet received treatment for their advanced disease. The main goal is t…

Matched conditions: SIEWERT TYPE 1 GEJ CANCER

Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

SIEWERT TYPE 1 GEJ CANCER

Get alerted when new SIEWERT TYPE 1 GEJ CANCER trials appear

New Two-Pronged attack on tough cancers shows promise